Henry Sandel, MD
Facial Plastic Surgery · Annapolis, MDNPI 1164624763
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,816 of the $2,266 with a category attached, or 80.1%. 8 manufacturers reported payments, led by Galderma Laboratories, L.p. at 40.2% of the total.
Across 104 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$911
- AbbVie$677
- Revance Therapeutics, Inc.$394
- Sientra, Inc.$123
- Motiva USA, LLC$69
- Pacira Pharmaceuticals Incorporated$40
- plus $52 from 2 others
What the payments were for
- Speaking & faculty fees$45020%
- Food & beverage$1,81680%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 23 | $911 |
| AbbVie(2 entities) | 55 | $677 |
| Revance Therapeutics, Inc. | 17 | $394 |
| Sientra, Inc. | 4 | $123 |
| Motiva USA, LLC | 1 | $69 |
| Pacira Pharmaceuticals Incorporated | 2 | $40 |
| Fidia Pharma USA Inc. | 1 | $30 |
| Merz North America, Inc. | 1 | $22 |
How this compares
Too few facial plastic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 23 | $520 |
| Azithromycin | 65 | $288 |
| Ondansetron OdtOndansetron | 52 | $127 |
| Tramadol Hcl | 59 | $71 |
| Diazepam | 38 | $42 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Annapolis
- Brandon WachalAnnapolis$4K
- Randolph CaponeBaltimore$44K
- Theda KontisBaltimore$16K
- Ira PapelBaltimore$6K
- Lee KleimanSeverna Park$4K
- Jennifer PorterBethesda$2K
- Jigar SitaparaColumbia$1K
- Thong leEllicott City$539
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.